JP2012513193A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012513193A5 JP2012513193A5 JP2011541487A JP2011541487A JP2012513193A5 JP 2012513193 A5 JP2012513193 A5 JP 2012513193A5 JP 2011541487 A JP2011541487 A JP 2011541487A JP 2011541487 A JP2011541487 A JP 2011541487A JP 2012513193 A5 JP2012513193 A5 JP 2012513193A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- tfpi
- amino acids
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08172522.8 | 2008-12-22 | ||
| EP08172522 | 2008-12-22 | ||
| PCT/EP2009/067566 WO2010072687A1 (en) | 2008-12-22 | 2009-12-18 | Antibodies against tissue factor pathway inhibitor (tfpi) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012513193A JP2012513193A (ja) | 2012-06-14 |
| JP2012513193A5 true JP2012513193A5 (https=) | 2012-12-13 |
| JP5791512B2 JP5791512B2 (ja) | 2015-10-07 |
Family
ID=42104649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011541487A Expired - Fee Related JP5791512B2 (ja) | 2008-12-22 | 2009-12-18 | 組織因子経路阻害因子(tfpi)に対する抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US8618263B2 (https=) |
| EP (1) | EP2379599B1 (https=) |
| JP (1) | JP5791512B2 (https=) |
| CN (1) | CN102300876A (https=) |
| TW (1) | TW201026329A (https=) |
| WO (1) | WO2010072687A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010072691A1 (en) * | 2008-12-22 | 2010-07-01 | Novo Nordisk A/S | Antibodies against tissue factor pathway inhibitor |
| PT3345615T (pt) | 2010-03-01 | 2020-01-17 | Bayer Healthcare Llc | Anticorpos monoclonais otimizados contra inibidor da via do fator tecidual (tfpi) |
| US9228022B2 (en) | 2010-06-30 | 2016-01-05 | Novo Nordisk A/S | Antibodies that are capable of specifically binding tissue factor pathway inhibitor |
| JP2013533871A (ja) * | 2010-06-30 | 2013-08-29 | ノヴォ ノルディスク アー/エス | 組織因子経路インヒビターに特異的に結合することが可能な抗体 |
| US9896513B2 (en) | 2013-03-15 | 2018-02-20 | Novo Nordisk A/S | Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitor |
| US10231993B2 (en) | 2013-06-27 | 2019-03-19 | University Of Washington Through Its Center For Commercialization | Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders |
| EP3022228B1 (en) | 2013-07-19 | 2019-02-27 | Novo Nordisk A/S | Antibodies recognizing the n-terminal part of tissue factor pathway inhibitor capable of eliciting pro-coagulant activity |
| JP6783754B2 (ja) * | 2014-09-17 | 2020-11-11 | ノヴォ ノルディスク アー/エス | 組織因子経路インヒビター(1〜161)上の2つのエピトープに結合する能力がある抗体 |
| MY178445A (en) * | 2015-02-25 | 2020-10-13 | Mogam Inst Biomedical Res | Novel antibody binding to tfpi and composition comprising the same |
| KR102438650B1 (ko) | 2015-08-19 | 2022-08-31 | 화이자 인코포레이티드 | 조직 인자 경로 억제제 항체 및 그의 용도 |
| CA3115607A1 (en) | 2018-10-11 | 2020-04-16 | Pfizer Inc. | Dosage regimen for tfpi antagonists |
| CN112442127A (zh) * | 2019-08-29 | 2021-03-05 | 苏州康宁杰瑞生物科技有限公司 | 针对tfpi的单克隆抗体 |
| WO2025124481A1 (zh) * | 2023-12-13 | 2025-06-19 | 苏州康宁杰瑞生物科技有限公司 | Tfpi抗体用于治疗血友病 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0539975A1 (en) * | 1991-10-31 | 1993-05-05 | Teijin Limited | Method for immunological assay of free lipoprotein-associated coagulation inhibitor (LACI) and kit therefor |
| JPH0875736A (ja) * | 1994-09-06 | 1996-03-22 | Chemo Sero Therapeut Res Inst | ヒト組織因子凝固系インヒビターの定量法 |
-
2009
- 2009-12-18 EP EP09793538.1A patent/EP2379599B1/en not_active Not-in-force
- 2009-12-18 WO PCT/EP2009/067566 patent/WO2010072687A1/en not_active Ceased
- 2009-12-18 US US13/140,840 patent/US8618263B2/en not_active Expired - Fee Related
- 2009-12-18 JP JP2011541487A patent/JP5791512B2/ja not_active Expired - Fee Related
- 2009-12-18 CN CN2009801555207A patent/CN102300876A/zh not_active Withdrawn
- 2009-12-22 TW TW098144131A patent/TW201026329A/zh unknown
-
2013
- 2013-08-28 US US14/012,204 patent/US20130344090A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012513193A5 (https=) | ||
| JP2012505912A5 (https=) | ||
| NO20083793L (no) | Antistoffer mot amyloid-beta peptid | |
| RU2015120804A (ru) | Антагонисты активина-actrii и их применение для лечения нарушений костной ткани и других нарушений | |
| WO2008101985A3 (en) | Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization | |
| PH12019500644A1 (en) | Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections | |
| JP2018168176A5 (https=) | ||
| JP2016529229A5 (https=) | ||
| CY1123008T1 (el) | Συνθεσεις raav-γουανυλικης κυκλασης και μεθοδοι για τη θεραπευτικη αντιμετωπιση της συγγενους αμαυρωσης 1 toy leber (lca1) | |
| EA201892184A1 (ru) | Оптимизированные моноклональные антитела против ингибитора пути тканевого фактора | |
| JP2010202664A5 (https=) | ||
| JP2016504275A5 (https=) | ||
| WO2009086539A3 (en) | Treatment and prophylaxis of amyloidosis | |
| JP2016521688A5 (https=) | ||
| GEP20115324B (en) | Tweak binding antibodies | |
| AR086579A1 (es) | Proteinas de union a antigeno | |
| JP2008508859A5 (https=) | ||
| RU2534564C3 (ru) | Мультиспецифическая связывающая антиген молекула, которая обладает альтернативной функцией к функции фактора свертывания крови viii | |
| MX355181B (es) | Anticuerpos humanos contra el factor tisular. | |
| WO2010017196A3 (en) | Monoclonal antibodies against tissue factor pathway inhibitor (tfpi) | |
| HRP20161656T4 (hr) | Sredstva za vezanje na cd33 | |
| EA201301107A1 (ru) | Моноклональные антитела против ингибитора пути тканевого фактора (tfpi) | |
| JP2018512124A5 (https=) | ||
| EA201290525A1 (ru) | Новые антитела-антагонисты, их fab-фрагменты против gpvi и способы их применения | |
| JP2013520996A5 (https=) |